Union Bancaire Privee UBP SA Takes Position in ARK Genomic Revolution ETF (BATS:ARKG)

Union Bancaire Privee UBP SA purchased a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,910 shares of the company’s stock, valued at approximately $45,000.

Other institutional investors also recently added to or reduced their stakes in the company. Hemington Wealth Management grew its position in shares of ARK Genomic Revolution ETF by 44.6% during the fourth quarter. Hemington Wealth Management now owns 1,310 shares of the company’s stock worth $30,000 after acquiring an additional 404 shares during the last quarter. Wealthcare Advisory Partners LLC grew its position in ARK Genomic Revolution ETF by 2.8% during the 4th quarter. Wealthcare Advisory Partners LLC now owns 15,903 shares of the company’s stock worth $374,000 after purchasing an additional 435 shares during the last quarter. Crescent Grove Advisors LLC grew its position in ARK Genomic Revolution ETF by 1.6% during the 3rd quarter. Crescent Grove Advisors LLC now owns 28,914 shares of the company’s stock worth $740,000 after purchasing an additional 460 shares during the last quarter. National Bank of Canada FI increased its stake in ARK Genomic Revolution ETF by 28.4% in the third quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after purchasing an additional 920 shares during the period. Finally, Ping Capital Management Inc. raised its holdings in shares of ARK Genomic Revolution ETF by 7.1% in the fourth quarter. Ping Capital Management Inc. now owns 15,000 shares of the company’s stock valued at $353,000 after buying an additional 1,000 shares during the last quarter.

ARK Genomic Revolution ETF Stock Performance

BATS ARKG opened at $25.21 on Wednesday. The business’s 50-day moving average is $25.88 and its 200-day moving average is $25.41.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.